843 related articles for article (PubMed ID: 28179279)
1. Role of RUNX1 in hematological malignancies.
Sood R; Kamikubo Y; Liu P
Blood; 2017 Apr; 129(15):2070-2082. PubMed ID: 28179279
[TBL] [Abstract][Full Text] [Related]
2. The Clinical, Molecular, and Mechanistic Basis of RUNX1 Mutations Identified in Hematological Malignancies.
Yokota A; Huo L; Lan F; Wu J; Huang G
Mol Cells; 2020 Feb; 43(2):145-152. PubMed ID: 31964134
[TBL] [Abstract][Full Text] [Related]
3. Genetic compensation of RUNX family transcription factors in leukemia.
Kamikubo Y
Cancer Sci; 2018 Aug; 109(8):2358-2363. PubMed ID: 29883054
[TBL] [Abstract][Full Text] [Related]
4. RUNX1 and CBFβ Mutations and Activities of Their Wild-Type Alleles in AML.
Hyde RK; Liu P; Friedman AD
Adv Exp Med Biol; 2017; 962():265-282. PubMed ID: 28299663
[TBL] [Abstract][Full Text] [Related]
5. Hematopoietic stem cells acquire survival advantage by loss of RUNX1 methylation identified in familial leukemia.
Matsumura T; Nakamura-Ishizu A; Muddineni SSNA; Tan DQ; Wang CQ; Tokunaga K; Tirado-Magallanes R; Sian S; Benoukraf T; Okuda T; Asou N; Matsuoka M; Osato M; Suda T
Blood; 2020 Oct; 136(17):1919-1932. PubMed ID: 32573733
[TBL] [Abstract][Full Text] [Related]
6. Biological Activities of RUNX1 Mutants Predict Secondary Acute Leukemia Transformation from Chronic Myelomonocytic Leukemia and Myelodysplastic Syndromes.
Tsai SC; Shih LY; Liang ST; Huang YJ; Kuo MC; Huang CF; Shih YS; Lin TH; Chiu MC; Liang DC
Clin Cancer Res; 2015 Aug; 21(15):3541-51. PubMed ID: 25840971
[TBL] [Abstract][Full Text] [Related]
7. Clinical Relevance of RUNX1 and CBFB Alterations in Acute Myeloid Leukemia and Other Hematological Disorders.
Metzeler KH; Bloomfield CD
Adv Exp Med Biol; 2017; 962():175-199. PubMed ID: 28299658
[TBL] [Abstract][Full Text] [Related]
8. RUNX1 mutations in clonal myeloid disorders: from conventional cytogenetics to next generation sequencing, a story 40 years in the making.
Mangan JK; Speck NA
Crit Rev Oncog; 2011; 16(1-2):77-91. PubMed ID: 22150309
[TBL] [Abstract][Full Text] [Related]
9. Runx transcription factors in the development and function of the definitive hematopoietic system.
de Bruijn M; Dzierzak E
Blood; 2017 Apr; 129(15):2061-2069. PubMed ID: 28179276
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms that produce secondary MDS/AML by RUNX1/AML1 point mutations.
Harada Y; Harada H
J Cell Biochem; 2011 Feb; 112(2):425-32. PubMed ID: 21268063
[TBL] [Abstract][Full Text] [Related]
11. Core binding factor genes and human leukemia.
Hart SM; Foroni L
Haematologica; 2002 Dec; 87(12):1307-23. PubMed ID: 12495904
[TBL] [Abstract][Full Text] [Related]
12. Familial platelet disorder with propensity to acute myelogenous leukemia: genetic heterogeneity and progression to leukemia via acquisition of clonal chromosome anomalies.
Minelli A; Maserati E; Rossi G; Bernardo ME; De Stefano P; Cecchini MP; Valli R; Albano V; Pierani P; Leszl A; Sainati L; Lo Curto F; Danesino C; Locatelli F; Pasquali F
Genes Chromosomes Cancer; 2004 Jul; 40(3):165-71. PubMed ID: 15138996
[TBL] [Abstract][Full Text] [Related]
13. RUNX1 deficiency (familial platelet disorder with predisposition to myeloid leukemia, FPDMM).
Schlegelberger B; Heller PG
Semin Hematol; 2017 Apr; 54(2):75-80. PubMed ID: 28637620
[TBL] [Abstract][Full Text] [Related]
14. Runx1 deficiency predisposes mice to T-lymphoblastic lymphoma.
Kundu M; Compton S; Garrett-Beal L; Stacy T; Starost MF; Eckhaus M; Speck NA; Liu PP
Blood; 2005 Nov; 106(10):3621-4. PubMed ID: 16051740
[TBL] [Abstract][Full Text] [Related]
15. Mutational landscape of patients with acute myeloid leukemia or myelodysplastic syndromes in the context of RUNX1 mutation.
Wang K; Zhou F; Cai X; Chao H; Zhang R; Chen S
Hematology; 2020 Dec; 25(1):211-218. PubMed ID: 32476595
[No Abstract] [Full Text] [Related]
16. RUNX1 meets MLL: epigenetic regulation of hematopoiesis by two leukemia genes.
Koh CP; Wang CQ; Ng CE; Ito Y; Araki M; Tergaonkar V; Huang G; Osato M
Leukemia; 2013 Sep; 27(9):1793-802. PubMed ID: 23817177
[TBL] [Abstract][Full Text] [Related]
17. Bone marrow pathologic abnormalities in familial platelet disorder with propensity for myeloid malignancy and germline RUNX1 mutation.
Kanagal-Shamanna R; Loghavi S; DiNardo CD; Medeiros LJ; Garcia-Manero G; Jabbour E; Routbort MJ; Luthra R; Bueso-Ramos CE; Khoury JD
Haematologica; 2017 Oct; 102(10):1661-1670. PubMed ID: 28659335
[TBL] [Abstract][Full Text] [Related]
18. New mechanisms of AML1 gene alteration in hematological malignancies.
Roumier C; Fenaux P; Lafage M; Imbert M; Eclache V; Preudhomme C
Leukemia; 2003 Jan; 17(1):9-16. PubMed ID: 12529654
[TBL] [Abstract][Full Text] [Related]
19. RUNX1 mutations promote leukemogenesis of myeloid malignancies in ASXL1-mutated leukemia.
Bera R; Chiu MC; Huang YJ; Lin TH; Kuo MC; Shih LY
J Hematol Oncol; 2019 Oct; 12(1):104. PubMed ID: 31640815
[TBL] [Abstract][Full Text] [Related]
20. [Transcription factor RUNX1].
Markova EN; Petrova NV; Razin SV; Kantidze OL
Mol Biol (Mosk); 2012; 46(6):846-59. PubMed ID: 23350231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]